COMMUNIQUÉS West-GlobeNewswire

Captor Capital: A Hidden Gem Growing Quickly in the Attractive Cannabis Sector -- CFN Media
30/08/2018
SEATTLE, Aug. 30, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
ContraVir Pharmaceuticals Announces Participation at the 20th Annual Global Investment Conference in New York City September 4-6, 2018
30/08/2018
EDISON, N.J., Aug. 30, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]
CV Sciences, Inc. provides corporate update to shareholders
30/08/2018
LAS VEGAS, Aug. 30, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) would like to assure our shareholders that we are keenly aware of recent market activity and [...]
ICC Labs Files Financial Results for the Second Quarter Ended June 30 and Completes the Construction of Its 124,000 sq. ft. Greenhouse in Colombia to Produce Psychoactive Medicinal Cannabis
30/08/2018
VANCOUVER, British Columbia, Aug. 30, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (“ ICC Labs ” or the “ Company ”) (TSX-V: ICC) is pleased to announce that it has filed its interim financial results for the second quarter [...]
Cesca Therapeutics to Present at the H.C. Wainwright 20th Annual Global Investment Conference
30/08/2018
RANCHO CORDOVA, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that [...]
Ultragenyx to Present at Upcoming Investor Conferences
30/08/2018
NOVATO, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced [...]
Dragon Jade to Acquire Montrose Group
30/08/2018
HONG KONG, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Dragon Jade International Limited (“Dragon Jade” or “the Company”) (OTCQX: DGJI), a provider of premier products and services, today announced that it has entered into a [...]
Avinger Announces 510(k) Filing of Pantheris Small Vessel Device
30/08/2018
Anticipated to Expand Addressable Market for Pantheris Family REDWOOD CITY, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery [...]
Anchiano Therapeutics Appoints Efrat Makov to its Board of Directors
30/08/2018
Former CFO of Alvarion brings decades of experience to Board CAMBRIDGE, Mass., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (TASE: ANCN), a clinical-stage biopharmaceutical company focused on the [...]
Marrone Bio Innovations, Inc. to Present at the H.C. Wainwright 20th Annual Global Investment Conference in New York
30/08/2018
DAVIS, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (the “Company” or “MBI”) (NASDAQ: MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf [...]
Biomerica Announces Fiscal Year End 2018 Financial Results
30/08/2018
IRVINE, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today reported net sales for the fiscal year 2018 were $5,564,185 versus net sales of $5, [...]
Auris Medical Receives FDA Guidance at Type C Meeting for AM-111 in the Treatment of Sudden Sensorineural Hearing Loss
30/08/2018
Zug, Switzerland, August 30, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and mental disorders [...]
Allscripts to present at the 2018 Wells Fargo Healthcare Conference
30/08/2018
CHICAGO, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) today announced that certain members of its management team will present at the 2018 Wells Fargo Healthcare Conference in Boston, MA on Wednesday, [...]
Daré Bioscience, Inc. to Present at the H.C. Wainwright 20th Annual Global Investment Conference
30/08/2018
Update on recent discussions with the FDA on the Topical 5% Sildenafil Citrate Cream for Female Sexual Arousal Disorder, and on other protofolio programs SAN DIEGO, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc [...]
Alder BioPharmaceuticals® to Present at Two Upcoming September Investor Conferences
30/08/2018
BOTHELL, Wash., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Rexahn Pharmaceuticals to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
30/08/2018
ROCKVILLE, Md., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, [...]
Caladrius Biosciences to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
30/08/2018
BASKING RIDGE, N.J., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]
Replimune Reports Financial Results for the First Fiscal Quarter, Ended June 30, and Provides Development and Corporate Update
30/08/2018
Completed initial public offering raising $111 million in total gross proceeds Entered into strategic collaboration with Regeneron Pharmaceuticals Signed lease for 63,000 sq. ft. manufacturing facility WOBURN, Mass., [...]
Catalyst Biosciences to Present at H.C. Wainwright & Co. 20th Annual Global Investment Conference
30/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications [...]

Pages